| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/11/2008 | CN101194898A Adhesive preparation |
| 06/11/2008 | CN101194897A Method for preparing water-solubility compound vitamin microcapsule |
| 06/11/2008 | CN101194896A Dropping pills containing berberine or berberine salt and method for preparing the same |
| 06/11/2008 | CN101194895A Dropping pills containing ursolic acid and method for preparing the same |
| 06/11/2008 | CN101194894A Dropping pills containing tegaserod maleate and method for preparing the same |
| 06/11/2008 | CN101194893A Dropping pills containing lovastatin and method for preparing the same |
| 06/11/2008 | CN101194892A Dropping pills containing benproperine phosphate and method for preparing the same |
| 06/11/2008 | CN101194891A Dropping pills containing bulleyaconitine and method for preparing the same |
| 06/11/2008 | CN101194890A Oral cavity rapid disintegrating tablet medicament and method of preparing the same |
| 06/11/2008 | CN101194889A Cyclosporin A nano-grain self-emulsifying freeze drying powder preparations and method for preparing the same |
| 06/11/2008 | CN101194888A Drotaverin HCl freeze-dried powder needle injection and method for producing the same |
| 06/11/2008 | CN100393359C Multi-element composition for eliminating pylorus spiro-bacillus |
| 06/11/2008 | CN100393355C Externally applied medicine for stopping hair shed and generating hair and its preparation method |
| 06/11/2008 | CN100393352C Local external application medicine for treating appendicitis and preparing method |
| 06/11/2008 | CN100393351C Use of composition in preparing medicament for preventing and treating anypnia |
| 06/11/2008 | CN100393349C Analgetic and its use |
| 06/11/2008 | CN100393343C Externally applied Chinese medicine liniment for treating skin diseases |
| 06/11/2008 | CN100393341C Hyperosteogeny-treating ointment |
| 06/11/2008 | CN100393340C Externally applied medicine for treating femoral head necrosis and preparation method thereof |
| 06/11/2008 | CN100393334C A method for preparing fat-reducing medicine |
| 06/11/2008 | CN100393332C Tissue regenerating ointment with repercussive and toxin-draining functions |
| 06/11/2008 | CN100393331C Composition for preventing and treating stomatosis and its preparing method |
| 06/11/2008 | CN100393330C Method for preparing red sage formulation or buccal tablet for treating coronary disease |
| 06/11/2008 | CN100393329C Chinese medicine preparation compound Huangdai tablet for treating leukemia and its preparing method |
| 06/11/2008 | CN100393327C Chewing tablet of Taishan radix cynanchi bungei, its preparing method and use |
| 06/11/2008 | CN100393322C Separate type medical material |
| 06/11/2008 | CN100393321C Oral antilipemic liquid and its preparing method |
| 06/11/2008 | CN100393319C Astragaloside cyclodextrin clathrate, its preparation and preparing mehtod |
| 06/11/2008 | CN100393318C Asiaticoside external use sterile powder and its preparation method |
| 06/11/2008 | CN100393317C Polyene phosphatidyl choline infusion solution and its preparing method |
| 06/11/2008 | CN100393316C Suppository containing prazosin hydrochloride, its preparation method and application |
| 06/11/2008 | CN100393315C Novel nimodipine composition |
| 06/11/2008 | CN100393314C Combination of Liranaftate gelatin and preparation method |
| 06/11/2008 | CN100393313C Bilobalide B powder injection and its preparing method |
| 06/11/2008 | CN100393312C Soft capsule of mycophenolic acid or like and its preparing method |
| 06/11/2008 | CN100393311C Trimebutine maleate dispersion tablet |
| 06/11/2008 | CN100393310C Frozen powder injection of tiopronin |
| 06/11/2008 | CN100393308C Use of Coleus forskohlii extract agent in tumor growth and preliferation inhibiting agent |
| 06/11/2008 | CN100393307C Multicomponent integrated plaster and its preparing process |
| 06/11/2008 | CN100393306C Formulation for treating mammary gland proliferation |
| 06/11/2008 | CN100393305C Montelukast oral disintegrating tablet formulation and its preparing method |
| 06/11/2008 | CN100393304C Fine granules containing acid-labile medicine and preparation thereof |
| 06/11/2008 | CN100393303C Vitamin A liposome artificial lacrimal eye drops |
| 06/11/2008 | CN100393302C Controlled releasing penetrant pump preparation for insoluble medicine composition |
| 06/11/2008 | CN100393301C Molecular gel transdermal medicine preparation and its preparing method |
| 06/11/2008 | CN100393296C Formula of making hollow capsule and its preparation method |
| 06/10/2008 | US7385068 Stearate composition and method |
| 06/10/2008 | US7384982 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/10/2008 | US7384972 administering a dietary indole, particularly Diindolylmethane (DIM), as well as its precursor, Indole-3-carbinol (I3C), and cogener, 2-(Indol-3-ylmethyl)-3,3'diindolylmethane (LTR-1), to reduce or prevent pain |
| 06/10/2008 | US7384971 Phytochemicals for the treatment of cervical dysplasia |
| 06/10/2008 | US7384923 Liposomes |
| 06/10/2008 | US7384919 Nontoxic; spray drying or freeze drying |
| 06/10/2008 | US7384786 Aligned scaffolds for improved myocardial regeneration |
| 06/10/2008 | US7384661 Continuous application of electrostatically charged powder material to the solid dosage form until voltage between the source of powder material and solid dosage form is so small that driving of powder to solid dosage is terminated |
| 06/10/2008 | US7384653 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 06/10/2008 | US7384652 Complexed-acidic-phospholipid-collagen composites for bone induction |
| 06/10/2008 | US7384651 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/10/2008 | US7384650 A skin permeation enhancer for enhancing absorption of a steroid hormone through the skin, containing an organic solvent, a fatty (C8-C20) alcohol ester of a hydroxy acid, a lower alkyl ester of hydroxy acid and a (C6-C18) fatty acid |
| 06/10/2008 | US7384649 Particulate compositions for pulmonary delivery |
| 06/10/2008 | US7384648 coatings selected from retinol, retinal, retinoic acid or p-[(E)-2-(5, 6, 7, 8-tetrahydro-5, 5, 8, 8-tetramethyll-2-naphthyl)propenyl]-benzoic acid, used as grafts for eye tissues; biodegradable prosthetics |
| 06/10/2008 | US7384645 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 06/10/2008 | US7384478 Apparatus and process for preparing crystalline particles |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | US7383970 Valve with a two-component seal |
| 06/10/2008 | CA2465675C Improved particulate compositions for pulmonary delivery |
| 06/10/2008 | CA2429590C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/10/2008 | CA2376121C Stable xylometazoline and oxymetazoline solution |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2345121C Pharmaceutical composition for the treatment of acute disorders |
| 06/10/2008 | CA2341814C Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/10/2008 | CA2329768C Pharmaceutical composition comprising factor viii and neutral liposomes |
| 06/10/2008 | CA2329234C Controlled release peroral compositions of levosimendan |
| 06/10/2008 | CA2326517C New galenic preparations of meloxicam for oral administration |
| 06/10/2008 | CA2319010C Pharmaceutical compositions |
| 06/10/2008 | CA2311530C Nasal solutions |
| 06/10/2008 | CA2310028C High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 06/10/2008 | CA2304331C Coated dosage units |
| 06/10/2008 | CA2302586C Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 06/10/2008 | CA2288287C Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 06/10/2008 | CA2286719C Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
| 06/10/2008 | CA2284107C Activation of peptides |
| 06/10/2008 | CA2250010C Denaturants for sympathomimetic amine salts |
| 06/10/2008 | CA2230730C Microemulsions for use as vehicles for administration of active compounds |
| 06/10/2008 | CA2214100C Sustained release formulation containing three different types of polymers |
| 06/10/2008 | CA2200595C Use of starch for transdermal applications |
| 06/10/2008 | CA2191750C Virosome-mediated intracellular delivery of therapeutic agents |
| 06/05/2008 | WO2008067573A2 Drug delivery system |
| 06/05/2008 | WO2008067485A1 Divisible osmotic dosage forms and methods of use |
| 06/05/2008 | WO2008067234A2 Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome |
| 06/05/2008 | WO2008067164A2 Solid pharmaceutical dosage formulations |
| 06/05/2008 | WO2008067049A2 Particles for cell targeting |
| 06/05/2008 | WO2008067037A2 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 06/05/2008 | WO2008066899A2 Nanoparticulate formulations and methods for the making and use thereof |
| 06/05/2008 | WO2008066832A2 Rapid detection of sulfhydryl compounds using a papain based assay |
| 06/05/2008 | WO2008066810A2 Pleasant tasting dry powder compositions suitable for pulmonary delivery |
| 06/05/2008 | WO2008066716A2 Film-coated solid dosage form |
| 06/05/2008 | WO2008066642A2 Transdermal delivery systems comprising bupivacaine |
| 06/05/2008 | WO2008066507A2 Nanotube devices for targeted delivery of therapeutic molecules |
| 06/05/2008 | WO2008066403A1 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
| 06/05/2008 | WO2008066301A1 Anticancer composition containing naphthoquinone-based compound for intestine delivery system |